At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for substantial growth and is projected to reach USD 13.4 billion by 2033. This ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...

The legume’s ability to support cellular function, enhance metabolic performance, and provide adaptive immune system support ...

Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed ...

A team of bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) -- a potent immune-boosting protein that holds promise for cancer treatment -- loses effectiveness ...

The University of Iowa has been selected among 22 other research teams to participate in the Advanced Research Projects ...

offering a sense of camaraderie and support. Cryptocurrency and blockchain technology are growing at an incredible rate, ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

Finding effective and natural solutions for women’s health can be daunting in today’s fast-paced world. For many women, ...

A team of Rice bioengineers has developed a mathematical model that clarifies why interleukin-12 ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over ...